Health

Cell-Free DNA (cfDNA) Testing Market Forecast, Revenue, Demand, Growth and Key Companies Valuation by 2028

September 8, 2021

The global Cell-Free DNA (cfDNA) Testing Market is forecasted to be worth USD 22.41 Billion by 2027, according to a new report by Emergen Research. The report provides Cell-Free DNA (cfDNA) Testing market forecast, supported by detailed insights historical data and revenues, past and current market trends, industry trends, consumer trends, market size, market share, market growth, along with ranging impacts of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in market size over the forecast period, 2024–2028. The global Cell-Free DNA (cfDNA) testing market is expected to grow significantly during the forecast period due to the increased incidence of cancers, rising prevalence of chromosome abnormalities in babies due to an increasing number of late pregnancy, and growing demand for non-invasive testing procedures. The report includes profiles of major players in the market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials. Besides, the increasing investments by governments to implement advanced therapeutic technology in hospitals is also expected to boost the market during the forecast period.

Download FREE Sample Brochure (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/156

Global Cell-Free DNA (cfDNA) Testing market forecast has been provided following thorough study, focus, comparison, and analysis of a varying range of factors and past market forecast and present outcomes. Rising focus by major companies on product/service expansion into new and untapped domestic markets, increasing investments in strategic agreements, favourable government policies and regulations, and growing competition in the market are some major trends observed in the Cell-Free DNA (cfDNA) Testing market. Development of more advanced offerings is driving rising demand and deployment in respective sectors/industries, and this is expected to drive Cell-Free DNA (cfDNA) Testing market revenue growth to a significant extent over the forecast period. Cell-Free DNA (cfDNA) Testing Market forecast is made possible through, but has not been limited to, a study and analysis of a variety of factors and trends, and these are verified through interviews with industry experts and companies operating in the market.

Browse Full Report Description with TOC@ https://www.emergenresearch.com/industry-report/cell-free-dna-market

Emergen Research has segmented the global Cell-Free DNA (cfDNA) Testing Market on the basis of type, technology, application, and region:

Type Outlook (Revenue, USD Billion; 2017-2027)
- Cell-free fetal DNA (NIPT)
- Circulating tumor DNA
- Donor-derived cell-free DNA
Technology Outlook (Revenue, USD Billion; 2017-2027)
- MPSS
- t-MPS
- SNP
- Others
Application Outlook (Revenue, USD Billion; 2017-2027)
- Transplantation
- Gynecology
- Oncology
Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
  1. U.S.
  2. Canada
  3. Mexico
- Europe
  1. Germany
  2. UK
  3. France
  4. BENELUX
  5. Rest of Europe
- Asia Pacific
  1. China
  2. Japan
  3. South Korea
  4. India
  5. Rest of APAC
- Latin America
  1. Brazil
  2. Rest of LATAM
- MEA
  1. Saudi Arabia
  2. UAE
  3. Rest of MEA

Incorporated with Info-graphics, charts, 70 tables and 85 figures, this 250-page research report “Cell-Free DNA (cfDNA) Testing Market Size, Type, Application, End-Use Industry, Regional Outlook, Competitive Strategies and Forecasts, 2024 – 2027” is based on a complete research of the entire Global market and covering all its sub-segments through comprehensively thorough classifications. Insightful analysis and assessment are created from superior primary and secondary information sources with data and information derived from industry specialists across the value chain.

Key Highlights From The Report

In August 2019, Agilent Technologies Inc. announced the acquisition of a leading manufacturer of innovative healthcare equipment, BioTek Instruments, Inc. This acquisition will expand Agilent’s product portfolio and its presence in North America.
Cell-free fetal DNA is a non-invasive procedure and therefore does not pose a health risk of CVS (chorionic villus sampling) or amniocentesis, like pain and any slight chance of infection. Due to these benefits, the cell-free fetal DNA segment held the largest market share of 48.8% in the Cell-Free DNA (cfDNA) testing market, in 2019.
The MPSS technology segment is anticipated to dominate the global market with a CAGR of 26.7%, owing to the advantage of producing a measurable profile of gene expression in cells or tissues.
The gynecology segment is anticipated to lead the market during the forecasted period, as the cell-free DNA approach is being used to detect genetic issues of baby and to diagnose pregnancy complications such as pregnancy loss.
North America is accounted for the largest market with a share of 33.6% in 2019, owing to the increasing chronic diseases and pregnancy problems in this region due to the changes in lifestyles of the population. Besides, the adoption of advanced technology in hospitals is also expected to boost the market shortly.
Key participants include Sequenom, Inc., Quest Diagnostics, Illumina Inc., Agilent Technologies, Inc., Guardant Health, Inc., Biodesix, Inc., Allenex AB, Roche Holdings AG, Biocept, Inc., and CareDx, Inc., among others.

Request customized copy of Cell-Free DNA (cfDNA) Testing report@ https://www.emergenresearch.com/request-for-customization/156

Region wise performance of the Cell-Free DNA (cfDNA) Testing industry

North America Cell-Free DNA (cfDNA) Testing market forecast is expected to remain significantly positive in terms of revenue share between 2024 and 2028. In addition, North America Cell-Free DNA (cfDNA) Testing market revenue share is expected to remain comparatively larger than that of other regional markets from 2024 to 2028.

Asia Pacific registered fastest revenue CAGR in 2024, and the Cell-Free DNA (cfDNA) Testing market forecast is that this trend is expected to continue going ahead. Market forecast states that revenue share contribution from China, India, and South Korea is expected to remain robust till 2028.

Europe Cell-Free DNA (cfDNA) Testing market forecast is positive currently, with revenue growth expected to remain steady between 2024 and 2028. Robust focus on research and development initiatives by major firms and changing trends and demographics in countries in the region are some factors expected to continue to support Cell-Free DNA (cfDNA) Testing market growth.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Table of Content

Chapter 1. Methodology & Sources

1.1. Cell-Free DNA (cfDNA) Testing Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid Sources

1.5. Cell-Free DNA (cfDNA) Testing Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2024-2028

Chapter 3. Key Insights

Chapter 4. Cell-Free DNA (cfDNA) Testing Market Segmentation & Impact Analysis

4.1. Cell-Free DNA (cfDNA) Testing Market Material Segmentation Analysis

4.2. Industrial Outlook

4.2.1. Cell-Free DNA (cfDNA) Testing Market indicators analysis

4.2.2. Cell-Free DNA (cfDNA) Testing Market drivers analysis

4.2.2.1. Rapid urbanization and industrialization

4.2.2.2. Stringent government regulations regarding carbon emissions

4.2.2.3. Increasing prevalence of respiratory diseases

4.2.2.4. Rising need to enhance indoor air quality

4.2.3. Cell-Free DNA (cfDNA) Testing Market restraints analysis

4.2.3.1. High cost associated with the maintenance of Cell-Free DNA (cfDNA) Testing products

4.2.3.2. Availability of renewable sources of energy

4.3. Technological Insights

4.4. Regulatory Framework

4.5. Porter’s Five Forces Analysis

4.6. Competitive Metric Space Analysis

4.7. Price trend Analysis

4.8. Covid-19 Impact Analysis

Chapter 10. Competitive Landscape

10.1. Cell-Free DNA (cfDNA) Testing Market Revenue Share By Manufacturers

10.2. Mergers & Acquisitions

10.3. Competitor’s Positioning

10.4. Strategy Benchmarking

10.5. Vendor Landscape

10.5.1. Raw Material Suppliers

10.5.1.1. North America

10.5.1.2. Europe

10.5.1.3. Asia Pacific

10.5.1.4. Middle East & Africa

10.5.1.5. Latin America

10.5.2. Distributors

10.5.2.1. North America

10.5.2.2. Europe

10.5.2.3. Asia Pacific

10.5.2.4. Middle East & Africa

10.5.2.5. Latin America

10.5.3. Others

Continued….

Avail Discount on Cell-Free DNA (cfDNA) Testing Market Report@ https://www.emergenresearch.com/request-discount/156

The research provides answers to the following key questions:

What will be the growth rate and the market size of the Cell-Free DNA (cfDNA) Testing industry for the forecast period 2024-2027?
What are the major driving forces expected to impact the development of the Cell-Free DNA (cfDNA) Testing market across different regions?
Who are the major driving forces expected to decide the fate of the Cell-Free DNA (cfDNA) Testing industry worldwide?
Who are the prominent market players making a mark in the Cell-Free DNA (cfDNA) Testing market with their winning strategies?
Which Cell-Free DNA (cfDNA) Testing industry trends are likely to shape the future of the industry during the forecast period 2024-2027?
What are the key barriers and threats believed to hinder the development of the industry?
What are the future opportunities in the Cell-Free DNA (cfDNA) Testing market?

Why Choose Emergen Research?